.png)
Sagent Pharmaceuticals Data Breach Investigation
Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in data breach cases, is investigating the Sagent Pharmaceuticals data breach.
If you were affected by the data breach, your sensitive personally identifiable information may have been exposed, and you may be eligible for compensation.
About Sagent Pharmaceuticals
Sagent Pharmaceuticals is a specialty pharmaceutical company focused on developing, producing, sourcing and marketing generic injectable pharmaceuticals. The company operates from its headquarters at 1901 N. Roselle Rd., Suite 450, Schaumburg, IL 60195.
What Happened?
Sagent Pharmaceuticals experienced a data breach involving unauthorized access to its network on or around Feb. 11, 2026.
The breach was investigated with the help of outside cybersecurity professionals, and the review concluded on March 23, 2026.
A threat actor known as Worldleaks claimed responsibility for the breach and posted about it on the dark web on March 8, 2026. The compromised data may have included sensitive personal and financial information.
Information Exposed:
- Driver's licenses
- Full names
- Social Security numbers
- Bank account information
- State identification numbers
- Health insurance policy information
1,383 total individuals were impacted as a result of the breach.
You May Be Entitled to Compensation
If your information was compromised in the Sagent Pharmaceuticals data breach, you may be entitled to compensation for damages related to the exposure of your personal data. Lawyers are ready to help affected individuals understand their rights and pursue potential claims.
To find out if you are eligible to join a lawsuit and seek compensation, complete the below form.
.svg)